Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • ID: 4372827
  • SWOT Analysis
  • 22 pages
  • GlobalData
  • Avanir Pharmaceuticals Inc
1 of 5

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Halozyme Therapeutics Inc
  • Impax Laboratories Inc
  • Nektar Therapeutics
  • Vivus Inc
  • MORE
Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
Highlights

Avanir Pharmaceuticals Inc (Avanir) a subsidiary of Otsuka America, Inc. is a biopharmaceutical company which focuses on developing medicines for patients suffering from central nervous system disorders. The company’s lead products include NUEDEXTA (AVP-923), a first-in-class dual N-methyl-D-aspartate (NMDA) rector antagonist and sigma-1 agonist is approved in the US and Europe for the treatment of pseudobulbar affect (PBA); and ONZETRA Xsail is for the treatment of migraine with or without aura in adult is approved in the US. Its AVP-786 has been developed for the treatment of depression and schizophrenia. The company is also developing various products under pipeline for the treatment of CNS disorders. Avanir is headquartered in Aliso Viejo, California, the US.

Avanir Pharmaceuticals Inc Key Recent Developments

Nov 29, 2017: Avanir restructures, will cut 11% of US workforce

Reasons to buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Halozyme Therapeutics Inc
  • Impax Laboratories Inc
  • Nektar Therapeutics
  • Vivus Inc
  • MORE
Section 1 - About the Company
  • Avanir Pharmaceuticals Inc - Key Facts
  • Avanir Pharmaceuticals Inc - Key Employees
  • Avanir Pharmaceuticals Inc - Key Employee Biographies
  • Avanir Pharmaceuticals Inc - Major Products and Services
  • Avanir Pharmaceuticals Inc - History
  • Avanir Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Avanir Pharmaceuticals Inc - Business Description
  • Avanir Pharmaceuticals Inc - Corporate Strategy
  • Avanir Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Avanir Pharmaceuticals Inc - Strengths
  • Avanir Pharmaceuticals Inc - Weaknesses
  • Avanir Pharmaceuticals Inc - Opportunities
  • Avanir Pharmaceuticals Inc - Threats
  • Avanir Pharmaceuticals Inc - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Avanir Pharmaceuticals Inc, Recent Deals Summary
Section 4 - Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Avanir Pharmaceuticals Inc, Key Facts
  • Avanir Pharmaceuticals Inc, Key Employees
  • Avanir Pharmaceuticals Inc, Key Employee Biographies
  • Avanir Pharmaceuticals Inc, Major Products and Services
  • Avanir Pharmaceuticals Inc, History
  • Avanir Pharmaceuticals Inc, Subsidiaries
  • Avanir Pharmaceuticals Inc, Key Competitors
  • Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Avanir Pharmaceuticals Inc, Recent Deals Summary
List of Figures
  • Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Vivus Inc
  • Sagent Pharmaceuticals Inc
  • Nektar Therapeutics
  • Impax Laboratories Inc
  • Halozyme Therapeutics Inc
  • Auxilium Pharmaceuticals LLC
  • Aegerion Pharmaceuticals Inc
  • Acorda Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll